Announcements Trials

Browse Landscape

Status

Approved for marketing 1

Sponsor Class

Study Type

Expanded_access 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Hairy Cell 1 Leukemia 1

Interventions

immunotoxin HA22 1 HA 22 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Approved for marketing × Leukemia, Hairy Cell × HA 22 × Clear all

NCT03501615 2020-06-29

MOXE

AstraZeneca

Approved for marketing

Other hematologic neoplasm

Leukemia, Leukemia, Hairy Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡